Your browser doesn't support javascript.
loading
Venetoclax and azacitidine therapy in acute myeloid leukemia patients with severe renal impairment.
Naka, Ryosuke; Kondo, Tadakazu; Nishikubo, Masashi; Muranushi, Hiroyuki; Ueda, Yasunori; Oka, Tomomi; Wada, Fumiya; Kanda, Junya; Yamamoto, Shohei; Watanabe, Mitsumasa; Okada, Shinri; Imada, Kazunori; Nakabo, Yukiharu; Mizutani, Yu; Nannya, Yasuhito; Ogawa, Seishi; Ishikawa, Takayuki.
Afiliación
  • Naka R; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Kondo T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Nishikubo M; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
  • Muranushi H; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Ueda Y; Department of Hematology/Oncology and Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
  • Oka T; Department of Hematology/Oncology and Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
  • Wada F; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
  • Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
  • Yamamoto S; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
  • Watanabe M; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Okada S; Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.
  • Imada K; Department of Hematology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.
  • Nakabo Y; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Osaka, Japan.
  • Mizutani Y; Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Osaka, Japan.
  • Nannya Y; The Center for Hematological Diseases, Takeda General Hospital, Kyoto, Kyoto, Japan.
  • Ogawa S; Department of Hematology, Hyogo Prefectural Tamba Medical Center, Tamba, Hyogo, Japan.
  • Ishikawa T; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
Am J Hematol ; 98(9): E251-E254, 2023 09.
Article en En | MEDLINE | ID: mdl-37381699
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda Límite: Humans Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Leucemia Mieloide Aguda Límite: Humans Idioma: En Revista: Am J Hematol Año: 2023 Tipo del documento: Article País de afiliación: Japón